Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Bihua Chen reported a 22.32% stake in Bridgebio Oncology Therapeutics, Inc. (Schedule 13D/A)
Event Jul 1, 2026 · Filed Jul 6, 2026
Bihua Chen reported a 22.32% stake in Bridgebio Oncology Therapeutics, Inc., 17,878,594 shares, with active intent on Jul 1, 2026. Filed Jul 6, 2026 (Schedule 13D/A).
- Stake
- 22.32%
- Shares
- 17,878,594
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bihua Chen | 22.32% | 17,878,594 |
| Cormorant Private Healthcare Fund III, LP | 6.09% | 4,879,995 |
| Cormorant Private Healthcare GP III, LLC | 6.09% | 4,879,995 |
| Cormorant Private Healthcare Fund V, LP | 6.25% | 5,010,332 |
| Cormorant Private Healthcare GP V, LLC | 6.25% | 5,010,332 |
| Cormorant Global Healthcare Master Fund, LP | 7.59% | 6,083,221 |
| Cormorant Global Healthcare GP, LLC | 7.59% | 6,083,221 |
| Helix Holdings II LLC | 0% | 0 |
Source
Related
- Bridgebio Oncology Therapeutics, Inc.
- Chen Bihua
- Bridgebio Oncology Therapeutics, Inc. shareholders
- Schedule 13D/A · Chen Bihua · Aug 13, 2025
- Form 4 · Beltran Pedro · Oct 5, 2026
- Form 4 · Ben Yong · Oct 5, 2026
- Form 4 · Elmelech Idan · Oct 5, 2026
- Form 4 · Cobo Marc · Oct 5, 2026
- Form 4 · Cobo Marc · Sep 14, 2026